Medicinal – Page 89

Synthesis of silver nanoparticles using Eucommia ulmoides extract and their potential biological function in cosmetics

mycolabadmin

Scientists created tiny silver particles using a Chinese medicinal plant extract and found they could help skin look lighter and younger. These particles work by reducing dark pigments and protecting skin from oxidative damage. The nanoparticles were safe at low doses and didn’t harm skin cells, making them promising for use in cosmetic products.

Complete mitochondrial genomic sequence of Auricularia delicata (Auriculariaceae), an edible Chinese mushroom

mycolabadmin

Scientists have sequenced the complete mitochondrial genome of Auricularia delicata, a popular edible jelly mushroom used in Chinese cuisine and traditional medicine. The genome is 189,696 base pairs long and contains 60 genes. This genetic information helps scientists understand how A. delicata is related to other mushroom species and provides a valuable resource for future research and cultivation of this important fungal species.

Targeted long-read sequencing analysis and antifungal susceptibility profiles of Sporothrix schenckii isolates from Thailand

mycolabadmin

Researchers in Thailand studied a fungal infection called sporotrichosis that affects both cats and people. They used advanced DNA sequencing technology to identify the specific type of fungus and understand how it’s related to similar fungi found in other parts of the world. They also tested how well common antifungal medications work against these fungi and found that some isolates are becoming harder to treat.

Recent innovations and challenges in the treatment of fungal infections

mycolabadmin

Fungal infections are becoming more common and dangerous, especially for people with weakened immune systems, and many fungi are developing resistance to current medications. Doctors and researchers are developing new treatment strategies, including combining multiple drugs together and using advanced technologies to deliver medicines more effectively to infected areas. Natural compounds from plants and new biotechnology tools like genetic engineering and nanoparticles show promising results for fighting drug-resistant fungal infections.

Pathogenic mucorales: Deciphering their cell wall polysaccharidome and immunostimulatory potential

mycolabadmin

Mucormycosis is a dangerous fungal infection that kills many immunocompromised patients. Researchers analyzed the outer layer (cell wall) of three common disease-causing fungi and discovered that their surfaces contain sugar-like molecules that trigger strong inflammatory responses from the immune system. This excessive inflammation may actually contribute to the disease’s severity, suggesting that controlling inflammation alongside antifungal treatment might improve patient outcomes.

Antifungal potential of Rhinacanthus nasutus extracts against the pathogenic fungus Cryptococcus neoformans

mycolabadmin

Researchers studied snake jasmine (Rhinacanthus nasutus), a plant used in traditional Thai medicine, to see if it could fight fungal infections caused by Cryptococcus neoformans, a dangerous pathogen that kills many people worldwide. They found that extract from the plant’s roots effectively slowed fungal growth and weakened the pathogen’s defenses by reducing its ability to produce protective melanin and capsules. Importantly, when combined with amphotericin B, a common antifungal drug, the plant extract worked even better together, suggesting it could enhance existing treatments.

Molecular Identification of Candida Species among Iranian Patients: Pursuing Candida auris

mycolabadmin

This study evaluated a simple molecular test called PCR-RFLP to identify different types of Candida fungi in hospitalized patients in Iran. Among 136 patient samples, researchers found eight different Candida species, with common Candida albicans being most prevalent, but other more dangerous species also present. No cases of the emerging pathogen Candida auris were found, though the test method can effectively detect it. The researchers conclude this cost-effective test could be valuable for identifying dangerous fungal infections in developing countries.

Pyrvinium Pamoate Synergizes with Azoles in vitro and in vivo to Exert Antifungal Efficacy Against Candida auris and Other Candida Species

mycolabadmin

Researchers tested a combination of an old antiparasitic drug called pyrvinium pamoate with common antifungal medications called azoles against dangerous drug-resistant fungal infections. While pyrvinium pamoate alone was not very effective, when combined with azoles it significantly improved the treatment of Candida auris infections. Tests in insect larvae showed that the combination improved survival rates better than using azoles alone, suggesting a promising new treatment approach for serious fungal infections.

John Perfect Shares Insights on Infectious Diseases, Antifungal Therapy, and Drug Resistance

mycolabadmin

This interview with Dr. John Perfect, a leading expert in fungal infections, discusses how antifungal treatments have evolved over his 48-year career. He explains that while fungal resistance is a concern, it’s less problematic than bacterial antibiotic resistance because fungi don’t spread resistance through plasmids. Dr. Perfect emphasizes the importance of newer, faster-acting antifungal drugs and combining drug therapy with immune system support to better treat serious fungal infections like cryptococcal meningitis and candidemia.

Exposure to Tebuconazole Drives Cross-Resistance to Clinical Triazoles in Aspergillus fumigatus

mycolabadmin

When farmers use antifungal pesticides called triazoles to protect crops, the fungi can develop resistance to these chemicals. This study found that when the fungus Aspergillus fumigatus is exposed to the agricultural triazole tebuconazole, it can become resistant not only to that pesticide but also to clinical triazole drugs used to treat human fungal infections. The resistant fungi maintain this resistance even when the pesticide is removed, suggesting that environmental pesticide use may threaten the effectiveness of medical antifungal treatments.

Research Topic: Medicinal